Weller M, Wick W, Aldape Ok, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, Reifenberger G. Glioma. Nat Critiques Illness Primers. 2015;1:15017.
Deuschl C, Kirchner J, Poeppel TD, Schaarschmidt B, Kebir S, El Hindy N, Hense J, Fast HH, Glas M, Herrmann Ok, et al. (11)C-MET PET/MRI for detection of recurrent glioma. Eur J Nucl Med Mol Imaging. 2018;45:593–601.
Xiao Z, Yao S, Wang ZM, Zhu DM, Bie YN, Zhang SZ, Chen WL. Multiparametric MRI options predict the SYP Gene expression in low-Grade Glioma sufferers: a machine learning-based Radiomics Evaluation. Entrance Oncol. 2021;11:663451.
Zhang L, Yang LQ, Wen L, Lv SQ, Hu JH, Li QR, Xu JP, Xu RF, Zhang D. Noninvasively evaluating the Grading of Glioma by Multiparametric Magnetic Resonance Imaging. Acad Radiol. 2021;28:e137–46.
Guo S, Xiong W, Zhu J, Feng J, Zhou R, Fan Q, Zhang Q, Li Z, Yang J, Zhou H, et al. A STING pathway-activatable distinction agent for MRI-guided Tumor immunoferroptosis synergistic remedy. Biomaterials. 2023;302:122300.
Lu Y, Liang Z, Feng J, Huang L, Guo S, Yi P, Xiong W, Chen S, Yang S, Xu Y, et al. Facile synthesis of weakly ferromagnetic Organogadolinium macrochelates-based T1‐Weighted magnetic resonance imaging distinction brokers. Adv Sci. 2022;10:e2205109.
Guo S, Wang L, Chen Q, Wang L, Zhang J, Zhu Y. Multimodal MRI picture resolution Fusion-Based mostly Community for Glioma classification. Entrance Oncol. 2022;12:819673.
Verburg N, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Heimans JJ, Rozemuller AJM, et al. Improved detection of diffuse glioma infiltration with imaging mixtures: a diagnostic accuracy examine. Neuro Oncol. 2020;22:412–22.
Dong L, Xu YJ, Sui C, Zhao Y, Mao LB, Gebauer D, Rosenberg R, Avaro J, Wu YD, Gao HL, et al. Extremely hydrated paramagnetic amorphous calcium carbonate nanoclusters as an MRI distinction agent. Nat Commun. 2022;13:5088.
Lu X, Zhou H, Liang Z, Feng J, Lu Y, Huang L, Qiu X, Xu Y, Shen Z. Biodegradable and biocompatible exceedingly small magnetic iron oxide nanoparticles for T1-weighted magnetic resonance imaging of tumors. J Nanobiotechnol. 2022;20:350.
Huang L, Zhu J, Xiong W, Feng J, Yang J, Lu X, Lu Y, Zhang Q, Yi P, Feng Y, et al. Tumor-generated reactive oxygen species Storm for high-performance ferroptosis remedy. ACS Nano. 2023;17:11492–506.
Fan Q, Xiong W, Zhou H, Yang J, Feng J, Li Z, Wu L, Hu F, Duan X, Li B et al. An AND Logic Gate for magnetic-resonance‐imaging‐guided ferroptosis remedy of tumors. Adv Mater 2023:2305932.
Yue R, Zhang C, Xu LH, Wang Y, Guan G, Lei L, Zhang X-B, Tune G. Twin key co-activated nanoplatform for switchable MRI monitoring correct ferroptosis-based synergistic remedy. Chem. 2022;8:1956–81.
Du Y, Qian M, Li C, Jiang H, Yang Y, Huang R. Facile marriage of Gd(3+) to polymer-coated carbon nanodots with enhanced biocompatibility for focused MR/fluorescence imaging of glioma. Int J Pharm. 2018;552:84–90.
Liu X, Madhankumar AB, Miller PA, Duck KA, Hafenstein S, Rizk E, Slagle-Webb B, Sheehan JM, Connor JR, Yang QX. MRI distinction agent for focusing on glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA. Neuro Oncol. 2016;18:691–9.
Yang CT, Chandrasekharan P, He T, Poh Z, Raju A, Chuang KH, Robins EG. An intravascular MRI distinction agent based mostly on Gd(DO3A-Lys) for Tumor angiography. Biomaterials. 2014;35:327–36.
Getzin T, Gueler F, Hartleben B, Gutberlet M, Thorenz A, Chen R, Meier M, Brasen JH, Derlin T, Hartung D, et al. Gd-EOB-DTPA-enhanced MRI for quantitative evaluation of liver organ injury after partial hepatic ischaemia reperfusion damage: correlation with histology and serum biomarkers of liver cell damage. Eur Radiol. 2018;28:4455–64.
Kobayashi H, Jo SK, Kawamoto S, Yasuda H, Hu X, Knopp MV, Brechbiel MW, Choyke PL, Star RA. Polyamine dendrimer-based MRI distinction brokers for practical kidney imaging to diagnose acute Renal Failure. J Magn Reson Imaging. 2004;20:512–8.
Martino F, Amici G, Rosner M, Ronco C, Novara G. Gadolinium-based distinction media nephrotoxicity in kidney impairment: the Physio-pathological situations for the Excellent Homicide. J Clin Med. 2021;10:271.
Muir BW, Acharya DP, Kennedy DF, Mulet X, Evans RA, Pereira SM, Wark KL, Boyd BJ, Nguyen TH, Hinton TM, et al. Steel-free and MRI seen theranostic lyotropic liquid crystal nitroxide-based nanoparticles. Biomaterials. 2012;33:2723–33.
Soikkeli M, Kettunen MI, Nivajarvi R, Olsson V, Ronkko S, Laakkonen JP, Lehto VP, Kavakka J, Heikkinen S. Evaluation of the Rest-Enhancing Properties of a Nitroxide-Based mostly Distinction Agent TEEPO-Glc with In Vivo Magnetic Resonance Imaging. Distinction Media Mol Imaging 2019, 2019:5629597.
Zhang C, Xu L, Nan B, Lu C, Liu H, Lei L, Yue R, Guan G, He M, Zhang XB, Tune G. Dynamic-reversible MRI nanoprobe for Steady Imaging Redox Homeostasis in hepatic ischemia-reperfusion Harm. ACS Nano. 2023;17:9529–42.
Soikkeli M, Horkka Ok, Moilanen JO, Timonen M, Kavakka J, Heikkinen S. Synthesis, Stability and Relaxivity of TEEPO-Met: an Natural Radical as a possible tumour focusing on distinction Agent for magnetic resonance imaging. Molecules. 2018;23:1034.
Emoto MC, Yamato M, Sato-Akaba H, Yamada Ok, Matsuoka Y, Fujii HG. Mind imaging in methamphetamine-treated mice utilizing a nitroxide distinction agent for EPR imaging of the redox standing and a gadolinium distinction agent for MRI statement of blood-brain barrier operate. Free Radic Res. 2015;49:1038–47.
Zhao W, Li Z, Liang N, Liu J, Yan P, Solar S. AIE-Featured Redox-Delicate Micelles for Bioimaging and environment friendly Anticancer Drug Supply. Int J Mol Sci. 2022;23:10801.
Wu C, Zhang Y, Jiang Y, Wang Q, Lengthy Y, Wang C, Cao X, Chen G. Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells. Cell Mol Immunol. 2013;10:393–402.
Li X, Guan S, Li H, Li D, Liu D, Wang J, Zhu W, Xing G, Yue L, Cai D, Zhang Q. Polysialic acid-functionalized liposomes for environment friendly honokiol supply to inhibit Breast most cancers development and Metastasis. Drug Deliv. 2023;30:2181746.
Zhang C, Ren J, He J, Ding Y, Huo D, Hu Y. Lengthy-term monitoring of tumor-related autophagy in vivo by Fe3O4NO. Nanoparticles. Biomaterials. 2018;179:186–98.
Binnemars-Postma Ok, Storm G, Prakash J. Nanomedicine methods to Goal Tumor-Related macrophages. Int J Mol Sci. 2017;18:979.
Zhao XW, van Beek EM, Schornagel Ok, Van der Maaden H, Van Houdt M, Otten MA, Finetti P, Van Egmond M, Matozaki T, Kraal G, et al. CD47-signal regulatory protein-α (SIRPα) interactions kind a barrier for antibody-mediated Tumor cell destruction. Proc Natl Acad Sci U S A. 2011;108:18342–7.
Xia D, Grasp D, Li Y, Jiang W, Zhu J, Ding Y, Gu H, Hu Y. Au-Hemoglobin loaded platelet assuaging Tumor Hypoxia and enhancing the Radiotherapy Impact with low-dose X-ray. ACS Nano. 2020;14:15654–68.
Gong H, Zhang L, Ma Y, Gui Y, Xiang T, Liu J, Fei S, Yue Ok, Li Q, Liu H, et al. Platelet shipped IL-10 enhances drug supply for attenuating I/R- or UUO-induced renal damage. Chem Eng J. 2023;462:142258.
Chen C, Tang Y, Huang H, Jia L, Feng L, Zhao J, Zhang H, He J, Ding L, Xia D. Relieving immunosuppression by Endo@PLT focusing on anti-angiogenesis to enhance the efficacy of immunotherapies. Chem Commun. 2022;58:3202–5.
Akiyama Y, Otsuka H, Nagasaki Y, Kato M, Kataoka Ok. Selective synthesis of heterobifunctional poly(ethylene glycol) derivatives containing each mercapto and acetal terminals. Bioconjug Chem. 2000;11:947–50.
Yoon YS, Oh H, Kim Y, Lim SP, Kim CS, Kang MW. Nafamostat mesilate: can it’s used as a conduit preserving agent in coronary artery bypass Surgical procedure? Korean J Thorac Cardiovasc Surg. 2013;46:413–25.
Zhao J, Ye H, Lu Q, Wang Ok, Chen X, Tune J, Wang H, Lu Y, Cheng M, He Z, et al. Inhibition of post-surgery tumour recurrence through a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs. J Nanobiotechnol. 2022;20:62.
Wang T, Zhou T, Xu M, Wang S, Wu A, Zhang M, Zhou YL, Shi J. Platelet membrane-camouflaged nanoparticles carry microRNA inhibitor in opposition to myocardial ischaemiareperfusion damage. J Nanobiotechnol. 2022;20:434.
Tang L, Yang S, Liang F, Wang Q, Qu X, Yang Z. Janus Nanocage towards platelet supply. ACS Appl Mater Interfaces. 2016;8:12056–62.
Tharkar P, Varanasi R, Wong WSF, Jin CT, Chrzanowski W. Nano-enhanced drug supply and therapeutic Ultrasound for Most cancers Remedy and Past. Entrance Bioeng Biotechnol. 2019;7:324.
Zhang Ok, Ma Z, Li S, Zhang W, Foda MF, Zhao Y, Han H. Platelet-covered nanocarriers for focused supply of Hirudin to remove thrombotic complication in Tumor Remedy. ACS Nano. 2022;16:18483–96.
Miao S, Zhang Q, Chang W, Wang J. New insights into platelet-enriched miRNAs: manufacturing, features, roles in tumors, and potential targets for Tumor prognosis and therapy. Mol Most cancers Ther. 2021;20:1359–66.
Yang H, Ding Y, Tong Z, Qian X, Xu H, Lin F, Sheng G, Hong L, Wang W, Mao Z. pH-responsive hybrid platelet membrane-coated nanobomb with deep Tumor penetration potential and enhanced most cancers thermal/chemodynamic remedy. Theranostics. 2022;12:4250–68.
Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S. Significance of chemokines and activated platelets in sufferers with Diabetes. Clin Exp Immunol. 2000;121:437–43.
Shi Q, Kuether EL, Chen Y, Schroeder JA, Fahs SA, Montgomery RR. Platelet gene remedy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human twine blood stem cells. Blood. 2014;123:395–403.
Jerome RN, Joly MM, Kennedy N, Shirey-Rice JK, Roden DM, Bernard GR, Holroyd KJ, Denny JC, Pulley JM. Leveraging Human Genetics to establish security indicators previous to Drug Advertising and marketing approval and scientific use. Drug Saf. 2020;43:567–82.
Wang M, Bao T, Yan W, Fang D, Yu Y, Liu Z, Yin G, Wan M, Mao C, Shi D. Nanomotor-based adsorbent for blood lead(II) removing in vitro and in pig fashions. Bioact Mater. 2021;6:1140–9.
Tan L, Li A, Yang Y, Zhang J, Niu X, Li N, Liu L, Guo L, Zhu Y. Extremely energetic and steady Li2S – Cu nanocomposite cathodes enabled by kinetically favored displacement interconversion between Cu2S and Li2S. Angew Chem Int Ed. 2022;61:e202206012.
Dong Z, Liang P, Guan G, Yin B, Wang Y, Yue R, Zhang X, Tune G. Overcoming Hypoxia-Induced Ferroptosis Resistance through a (19) F/(1) H-MRI Traceable Core-Shell Nanostructure. Angew Chem Int Ed Engl. 2022;61:e202206074.
Guan G, Zhang C, Liu H, Wang Y, Dong Z, Lu C, Nan B, Yue R, Yin X, Zhang XB, Tune G. Ternary Alloy PtWMn as a Mn Nanoreservoir for high-field MRI monitoring and extremely selective ferroptosis remedy. Angew Chem Int Ed Engl. 2022;61:e202117229.
Yang Y, Yang T, Chen F, Zhang C, Yin B, Yin X, Han L, Xie Q, Zhang XB, Tune G. Degradable magnetic nanoplatform with Hydroxide ions Triggered Photoacoustic, MR Imaging, and Photothermal Conversion for Exact Most cancers Theranostic. Nano Lett. 2022;22:3228–35.
Jayapaul J, Schröder L. Nanoparticle-Based mostly Distinction Brokers for (129)Xe HyperCEST NMR and MRI Functions. Distinction Media Mol Imaging 2019, 2019:9498173.
Vismara M, Negri S, Scolari F, Brunetti V, Trivigno SMG, Faris P, Galgano L, Soda T, Berra-Romani R, Canobbio I, et al. Platelet-derived extracellular vesicles stimulate Migration via partial remodelling of the ca(2+) dealing with Equipment in MDA-MB-231 Breast Most cancers cells. Cells. 2022;11:3120.
Li X, Hu L, Tan C, Wang X, Ran Q, Chen L, Li Z. Platelet-promoting drug supply effectivity for inhibition of Tumor development, Metastasis, and recurrence. Entrance Oncol. 2022;12:983874.
Liu J, Jiao L, Zhong X, Yao W, Du Ok, Lu S, Wu Y, Ma T, Tong J, Xu M, et al. Platelet activating issue receptor exaggerates microglia-mediated microenvironment by IL10-STAT3 signaling: a novel potential biomarker and goal for prognosis and therapy of Alzheimer’s Illness. Entrance Getting old Neurosci. 2022;14:856628.
Jiang L, Gao Z-m, Ye L, Zhang A-y. Feng Z-g: a tumor-targeting nano doxorubicin supply system constructed from amphiphilic polyrotaxane-based block copolymers. Polymer. 2013;54:5188–98.
Nguyen HV, Chen Q, Paletta JT, Harvey P, Jiang Y, Zhang H, Boska MD, Ottaviani MF, Jasanoff A, Rajca A, Johnson JA. Nitroxide-based macromolecular distinction brokers with unprecedented transverse Relaxivity and Stability for Magnetic Resonance Imaging of Tumors. ACS Cent Sci. 2017;3:800–11.
